Bedel Financial Consulting, Inc. Amgen Inc Transaction History

Bedel Financial Consulting, Inc.

$716 Million
Q3 2024

A detailed history of Bedel Financial Consulting, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Bedel Financial Consulting, Inc. holds 1,451 shares of AMGN stock, worth $427,363. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,451

Previous 1,457 0.41%

Holding current value

$427,363

Previous $455,000 2.64%

% of portfolio

0.07%

Previous 0.07%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $1,856 - $2,024	-6 Reduced 0.41%	1,451 $467,000
Q2 2024 Aug 05, 2024	BUY	$262.75 - $319.31 $2,627 - $3,193	10 Added 0.69%	1,457 $455,000
Q1 2024 May 07, 2024	SELL	$268.87 - $324.56 $1,344 - $1,622	-5 Reduced 0.34%	1,447 $411,000
Q4 2023 Feb 08, 2024	BUY	$255.7 - $288.46 $1,278 - $1,442	5 Added 0.35%	1,452 $418,000
Q4 2022 Feb 07, 2023	SELL	$229.03 - $291.01 $12,825 - $16,296	-56 Reduced 3.73%	1,447 $380,000
Q2 2021 Aug 03, 2021	BUY	$233.58 - $259.14 $58,395 - $64,785	250 Added 19.95%	1,503 $366,000
Q1 2021 Apr 26, 2021	BUY	$221.91 - $258.6 $22,191 - $25,860	100 Added 8.67%	1,253 $312,000
Q3 2020 Oct 20, 2020	SELL	$234.65 - $260.95 $2,346 - $2,609	-10 Reduced 0.86%	1,153 $293,000
Q2 2020 Jul 14, 2020	SELL	$197.81 - $242.74 $7,121 - $8,738	-36 Reduced 3.0%	1,163 $274,000
Q1 2020 May 06, 2020	BUY	$182.24 - $241.7 $2,915 - $3,867	16 Added 1.35%	1,199 $243,000
Q3 2019 Oct 09, 2019	BUY	$174.11 - $208.62 $2,089 - $2,503	12 Added 1.02%	1,183 $229,000
Q1 2018 May 03, 2018	SELL	$169.43 - $198.0 $12,707 - $14,850	-75 Reduced 6.02%	1,171 $200,000
Q4 2017 Feb 06, 2018	BUY	$168.79 - $188.59 $210,312 - $234,983	1,246	1,246 $217,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.

Account

Bedel Financial Consulting, Inc. Amgen Inc Transaction History